Literature DB >> 26743983

Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell line.

Camille Chenevier-Gobeaux1, Valérie Bardet2, Hélène Poupet3, Claire Poyart3, Didier Borderie4, Yann-Erick Claessens5.   

Abstract

Presepsin could help for early diagnosis of systemic infection. Little is known regarding its kinetics. We studied presepsin concentration after challenge with bacterial agonist lipopolysaccharide (LPS) stimulation in peripheral mononuclear cells (PMNC) collected from 5 healthy volunteers and in a human cell line of monocytic cells (THP1). In PMNC, an exposure to LPS (100 ng/mL) induced an increase of median presepsin levels as early as hour 1 (+31%, p=0.007), concomitantly to IL-6 synthesis. In THP1 cells, presepsin was detected at 1 hour after LPS exposure, and peaked at 3 hours, in THP1 cells. In conclusion, we report here that presepsin, a surrogate marker of the host response to bacteria, increases early in PMNC and in a monocytic cell lineage. Our findings might confirm the potential usefulness of presepsin bedside as an early marker of infectious diseases.

Entities:  

Keywords:  biomarkers; lipopolysaccharide; presepsin; sepsis

Mesh:

Substances:

Year:  2016        PMID: 26743983     DOI: 10.1684/abc.2015.1112

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  6 in total

Review 1.  Emerging infection and sepsis biomarkers: will they change current therapies?

Authors:  Lauren Jacobs; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-17       Impact factor: 5.091

2.  Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients.

Authors:  Yusuke Koizumi; Kaoru Shimizu; Masayo Shigeta; Takafumi Okuno; Hitoshi Minamiguchi; Katsuyuki Kito; Keiko Hodohara; Yuka Yamagishi; Akira Andoh; Yoshihide Fujiyama; Hiroshige Mikamo
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

3.  Advances and Pitfalls in Using Laboratory Biomarkers for the Diagnosis and Management of Sepsis.

Authors:  Dunja Rogić; Gordana Fressl Juroš; József Petrik; Ana Lončar Vrančić
Journal:  EJIFCC       Date:  2017-05-01

4.  Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis.

Authors:  Iris van Maldeghem; Charlotte M Nusman; Douwe H Visser
Journal:  BMC Immunol       Date:  2019-06-03       Impact factor: 3.615

5.  The Association between Dynamic Changes in Serum Presepsin Levels and Mortality in Immunocompromised Patients with Sepsis: A Prospective Cohort Study.

Authors:  Jongmin Lee; Seohyun Kim; Kyung Hoon Kim; Na Ri Jeong; Seok Chan Kim; Eun-Jee Oh
Journal:  Diagnostics (Basel)       Date:  2021-01-02

6.  Combined Use of Presepsin and (1,3)-β-D-glucan as Biomarkers for Diagnosing Candida Sepsis and Monitoring the Effectiveness of Treatment in Critically Ill Patients.

Authors:  Radim Dobiáš; Marcela Káňová; Naděžda Petejová; Štefan Kis Pisti; Robert Bocek; Eva Krejčí; Helena Stružková; Michaela Cachová; Hana Tomášková; Petr Hamal; Vladimír Havlíček; Milan Raška
Journal:  J Fungi (Basel)       Date:  2022-03-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.